5e3d2e218715acb47c41cef464e7cc33eee11302
config1.json
| ... | ... | @@ -1,12 +0,0 @@ |
| 1 | -{ |
|
| 2 | - "theme": "base", |
|
| 3 | - "themeVariables": { |
|
| 4 | - "fontSize": "33px" |
|
| 5 | - }, |
|
| 6 | - "sankey": { |
|
| 7 | - "height": 1000, |
|
| 8 | - "width": 800, |
|
| 9 | - "showValues": false, |
|
| 10 | - "linkColor": "target" |
|
| 11 | - } |
|
| 12 | -} |
config2.json
| ... | ... | @@ -1,12 +0,0 @@ |
| 1 | -{ |
|
| 2 | - "theme": "base", |
|
| 3 | - "themeVariables": { |
|
| 4 | - "fontSize": "33px" |
|
| 5 | - }, |
|
| 6 | - "sankey": { |
|
| 7 | - "height": 700, |
|
| 8 | - "width": 800, |
|
| 9 | - "showValues": false, |
|
| 10 | - "linkColor": "target" |
|
| 11 | - } |
|
| 12 | -} |
test_with_bib.md
| ... | ... | @@ -1,240 +0,0 @@ |
| 1 | -| Gene | Reference | |
|
| 2 | -|:---------:|:-----------------------------:| |
|
| 3 | -| ABL2 | (Russler-Germain et al. 2023) | |
|
| 4 | -| HIST1H2BD | (Krysiak et al. 2017) | |
|
| 5 | -| CPNE8 | (Hübschmann et al. 2021) | |
|
| 6 | -| HIST1H2AG | (Krysiak et al. 2017) | |
|
| 7 | -| BIRC6 | | |
|
| 8 | -| CXCR4 | (Krysiak et al. 2017) | |
|
| 9 | -| STAT6 | (Yildiz et al. 2015) | |
|
| 10 | -| CARD11 | (Morin et al. 2011) | |
|
| 11 | -| ITPKB | | |
|
| 12 | -| ACTG1 | (Hübschmann et al. 2021) | |
|
| 13 | -| HIST1H2BC | (Krysiak et al. 2017) | |
|
| 14 | -| POU2AF1 | (Krysiak et al. 2017) | |
|
| 15 | -| SESN1 | | |
|
| 16 | -| CILP | (Russler-Germain et al. 2023) | |
|
| 17 | -| MEF2C | | |
|
| 18 | -| PRKDC | (Hübschmann et al. 2021) | |
|
| 19 | -| TP53 | (Morin et al. 2011) | |
|
| 20 | -| KLF2 | | |
|
| 21 | -| MYCBP2 | (Hübschmann et al. 2021) | |
|
| 22 | -| BCL7A | (Krysiak et al. 2017) | |
|
| 23 | -| B2M | (Morin et al. 2011) | |
|
| 24 | -| VMA21 | (Hübschmann et al. 2021) | |
|
| 25 | -| BCL10 | (Russler-Germain et al. 2023) | |
|
| 26 | -| DUSP2 | | |
|
| 27 | -| MAP2K1 | (Louissaint et al. 2016) | |
|
| 28 | -| IGLL5 | (Russler-Germain et al. 2023) | |
|
| 29 | -| ZC3H12A | | |
|
| 30 | -| JUP | (Hübschmann et al. 2021) | |
|
| 31 | -| TMEM30A | (Morin et al. 2011) | |
|
| 32 | -| ATP6V1B2 | (Okosun et al. 2016) | |
|
| 33 | -| SOCS1 | | |
|
| 34 | -| CYP2A6 | (Russler-Germain et al. 2023) | |
|
| 35 | -| HIST1H3B | | |
|
| 36 | -| SRRM2 | (Russler-Germain et al. 2023) | |
|
| 37 | -| HIST1H3G | (Krysiak et al. 2017) | |
|
| 38 | -| HIST1H2AM | (Krysiak et al. 2017) | |
|
| 39 | -| GNA13 | (Morin et al. 2011) | |
|
| 40 | -| HIST1H1B | (Krysiak et al. 2017) | |
|
| 41 | -| PPP4C | (Hübschmann et al. 2021) | |
|
| 42 | -| MYD88 | | |
|
| 43 | -| PTPRD | | |
|
| 44 | -| EEF1A1 | (Hübschmann et al. 2021) | |
|
| 45 | -| CCND3 | (Morin et al. 2011) | |
|
| 46 | -| LAPTM5 | (Hübschmann et al. 2021) | |
|
| 47 | -| TNFAIP3 | | |
|
| 48 | -| HIST1H1C | (Morin et al. 2011) | |
|
| 49 | -| GBP7 | (Russler-Germain et al. 2023) | |
|
| 50 | -| XIRP2 | (Russler-Germain et al. 2023) | |
|
| 51 | -| GRM6 | (Russler-Germain et al. 2023) | |
|
| 52 | -| CREBBP | (Pasqualucci et al. 2011) | |
|
| 53 | -| SGK1 | (Morin et al. 2011) | |
|
| 54 | -| CD79B | | |
|
| 55 | -| ATP6AP1 | (Okosun et al. 2016) | |
|
| 56 | -| HNRNPD | | |
|
| 57 | -| OR8H2 | (Russler-Germain et al. 2023) | |
|
| 58 | -| IRF8 | (Morin et al. 2011) | |
|
| 59 | -| ZNF608 | (Krysiak et al. 2017) | |
|
| 60 | -| SHROOM3 | (Russler-Germain et al. 2023) | |
|
| 61 | -| HVCN1 | (Krysiak et al. 2017) | |
|
| 62 | -| TBL1XR1 | | |
|
| 63 | -| CD83 | (Russler-Germain et al. 2023) | |
|
| 64 | -| DTX1 | | |
|
| 65 | -| KLHL6 | (Morin et al. 2011) | |
|
| 66 | -| EBF1 | | |
|
| 67 | -| CD70 | (Russler-Germain et al. 2023) | |
|
| 68 | -| IRF4 | | |
|
| 69 | -| STAB2 | (Russler-Germain et al. 2023) | |
|
| 70 | -| TNFRSF14 | (Cheung et al. 2010) | |
|
| 71 | -| FAS | | |
|
| 72 | -| BTK | (Krysiak et al. 2017) | |
|
| 73 | -| FOXO1 | (Morin et al. 2011) | |
|
| 74 | -| SMARCA4 | (Krysiak et al. 2017) | |
|
| 75 | -| POU2F2 | (Krysiak et al. 2017) | |
|
| 76 | -| RRAGC | | |
|
| 77 | -| KIR3DL1 | (Russler-Germain et al. 2023) | |
|
| 78 | -| HIST1H1D | (Krysiak et al. 2017) | |
|
| 79 | -| BCL2 | (Morin et al. 2011) | |
|
| 80 | -| EGR1 | (Krysiak et al. 2017) | |
|
| 81 | -| ACTB | | |
|
| 82 | -| PZP | (Russler-Germain et al. 2023) | |
|
| 83 | -| GNAI2 | | |
|
| 84 | -| DHX15 | (Hübschmann et al. 2021) | |
|
| 85 | -| ATP6V1A | (Hübschmann et al. 2021) | |
|
| 86 | -| PDS5B | (Hübschmann et al. 2021) | |
|
| 87 | -| BCL6 | | |
|
| 88 | -| HIST1H2BM | (Krysiak et al. 2017) | |
|
| 89 | -| PIM1 | | |
|
| 90 | -| MEF2B | (Morin et al. 2011) | |
|
| 91 | -| EZH2 | (Morin et al. 2010) | |
|
| 92 | -| MAGEC1 | (Russler-Germain et al. 2023) | |
|
| 93 | -| KMT2D | (Morin et al. 2011) | |
|
| 94 | -| ARID1A | (Krysiak et al. 2017) | |
|
| 95 | -| MAP7D1 | (Russler-Germain et al. 2023) | |
|
| 96 | -| DDX3X | | |
|
| 97 | -| MGEA5 | (Hübschmann et al. 2021) | |
|
| 98 | -| MKI67 | (Russler-Germain et al. 2023) | |
|
| 99 | -| HIST1H3I | (Krysiak et al. 2017) | |
|
| 100 | -| CCDC42BPB | (Hübschmann et al. 2021) | |
|
| 101 | -| HIST1H1E | (Krysiak et al. 2017) | |
|
| 102 | -| TMSB4X | | |
|
| 103 | -| TPP1 | (Hübschmann et al. 2021) | |
|
| 104 | -| HLA-B | | |
|
| 105 | -| PCLO | | |
|
| 106 | -| FZR1 | (Hübschmann et al. 2021) | |
|
| 107 | -| S1PR2 | | |
|
| 108 | -| BTG1 | | |
|
| 109 | -| BTG2 | (Morin et al. 2011) | |
|
| 110 | -| HIST1H2BG | (Krysiak et al. 2017) | |
|
| 111 | -| LTB | | |
|
| 112 | -| EP300 | (Pasqualucci et al. 2011) | |
|
| 113 | -| CTSS | (Bararia et al. 2020) | |
|
| 114 | -| HIST1H2AC | (Krysiak et al. 2017) | |
|
| 115 | -| NFKBIA | (Russler-Germain et al. 2023) | |
|
| 116 | -| P2RY8 | | |
|
| 117 | -| RBM6 | (Hübschmann et al. 2021) | |
|
| 118 | -| MYC | | |
|
| 119 | - |
|
| 120 | -<div id="refs" class="references csl-bib-body hanging-indent"> |
|
| 121 | - |
|
| 122 | -<div id="ref-barariaCathepsinAlterationsInduce2020c" class="csl-entry"> |
|
| 123 | - |
|
| 124 | -Bararia, Deepak, Johannes A. Hildebrand, Sebastian Stolz, Sarah Haebe, |
|
| 125 | -Stefan Alig, Christopher P. Trevisani, Francisco Osorio-Barrios, et al. |
|
| 126 | -2020. “Cathepsin S Alterations Induce a Tumor-Promoting Immune |
|
| 127 | -Microenvironment in Follicular Lymphoma.” *Cell Reports* 31 (5): 107522. |
|
| 128 | -<https://doi.org/10.1016/j.celrep.2020.107522>. |
|
| 129 | - |
|
| 130 | -</div> |
|
| 131 | - |
|
| 132 | -<div id="ref-cheungAcquiredTNFRSF14Mutations2010a" class="csl-entry"> |
|
| 133 | - |
|
| 134 | -Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa |
|
| 135 | -Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al. |
|
| 136 | -2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated |
|
| 137 | -with Worse Prognosis.” *Cancer Research* 70 (22): 9166–74. |
|
| 138 | -<https://doi.org/10.1158/0008-5472.CAN-10-2460>. |
|
| 139 | - |
|
| 140 | -</div> |
|
| 141 | - |
|
| 142 | -<div id="ref-hubschmannMutationalMechanismsShaping2021b" |
|
| 143 | -class="csl-entry"> |
|
| 144 | - |
|
| 145 | -Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H. |
|
| 146 | -Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al. |
|
| 147 | -2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of |
|
| 148 | -Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.” |
|
| 149 | -*Leukemia* 35 (7): 2002–16. |
|
| 150 | -<https://doi.org/10.1038/s41375-021-01251-z>. |
|
| 151 | - |
|
| 152 | -</div> |
|
| 153 | - |
|
| 154 | -<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry"> |
|
| 155 | - |
|
| 156 | -Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, |
|
| 157 | -Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. |
|
| 158 | -“Recurrent Somatic Mutations Affecting <span |
|
| 159 | -class="nocase">B-cell</span> Receptor Signaling Pathway Genes in |
|
| 160 | -Follicular Lymphoma.” *Blood* 129 (4): 473–83. |
|
| 161 | -<https://doi.org/10.1182/blood-2016-07-729954>. |
|
| 162 | - |
|
| 163 | -</div> |
|
| 164 | - |
|
| 165 | -<div id="ref-louissaintPediatrictypeNodalFollicular2016a" |
|
| 166 | -class="csl-entry"> |
|
| 167 | - |
|
| 168 | -Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E. |
|
| 169 | -Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016. |
|
| 170 | -“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct |
|
| 171 | -Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 (8): |
|
| 172 | -1093–1100. <https://doi.org/10.1182/blood-2015-12-682591>. |
|
| 173 | - |
|
| 174 | -</div> |
|
| 175 | - |
|
| 176 | -<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry"> |
|
| 177 | - |
|
| 178 | -Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J. |
|
| 179 | -Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010. |
|
| 180 | -“Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse |
|
| 181 | -Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center |
|
| 182 | -Origin.” *Nature Genetics* 42 (2): 181–85. |
|
| 183 | -<https://doi.org/10.1038/ng.518>. |
|
| 184 | - |
|
| 185 | -</div> |
|
| 186 | - |
|
| 187 | -<div id="ref-morinFrequentMutationHistonemodifying2011" |
|
| 188 | -class="csl-entry"> |
|
| 189 | - |
|
| 190 | -Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, |
|
| 191 | -Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. |
|
| 192 | -“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” |
|
| 193 | -*Nature* 476 (7360): 298–303. <https://doi.org/10.1038/nature10351>. |
|
| 194 | - |
|
| 195 | -</div> |
|
| 196 | - |
|
| 197 | -<div id="ref-okosunRecurrentMTORC1activatingRRAGC2016a" |
|
| 198 | -class="csl-entry"> |
|
| 199 | - |
|
| 200 | -Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy |
|
| 201 | -Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016. |
|
| 202 | -“Recurrent <span class="nocase">mTORC1-activating RRAGC</span> Mutations |
|
| 203 | -in Follicular Lymphoma.” *Nature Genetics* 48 (2): 183–88. |
|
| 204 | -<https://doi.org/10.1038/ng.3473>. |
|
| 205 | - |
|
| 206 | -</div> |
|
| 207 | - |
|
| 208 | -<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a" |
|
| 209 | -class="csl-entry"> |
|
| 210 | - |
|
| 211 | -Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia |
|
| 212 | -Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011. |
|
| 213 | -“Inactivating Mutations of Acetyltransferase Genes in <span |
|
| 214 | -class="nocase">B-cell</span> Lymphoma.” *Nature* 471 (7337): 189–95. |
|
| 215 | -<https://doi.org/10.1038/nature09730>. |
|
| 216 | - |
|
| 217 | -</div> |
|
| 218 | - |
|
| 219 | -<div id="ref-russler-germainMutationsAssociatedProgression2023b" |
|
| 220 | -class="csl-entry"> |
|
| 221 | - |
|
| 222 | -Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew |
|
| 223 | -Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al. |
|
| 224 | -2023. “Mutations Associated with Progression in Follicular Lymphoma |
|
| 225 | -Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood |
|
| 226 | -Advances* 7: 5524–39. |
|
| 227 | -<https://doi.org/10.1182/bloodadvances.2023010779>. |
|
| 228 | - |
|
| 229 | -</div> |
|
| 230 | - |
|
| 231 | -<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry"> |
|
| 232 | - |
|
| 233 | -Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter |
|
| 234 | -Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6 |
|
| 235 | -Mutations in Follicular Lymphoma.” *Blood* 125 (4): 668–79. |
|
| 236 | -<https://doi.org/10.1182/blood-2014-06-582650>. |
|
| 237 | - |
|
| 238 | -</div> |
|
| 239 | - |
|
| 240 | -</div> |
tier1_pmbl_hl_gz.md
| ... | ... | @@ -1,76 +0,0 @@ |
| 1 | -| Category | Gene | Details | Mutation frequency | Static view (Gene) | Static view (Protein) | Comment | |
|
| 2 | -| :---: | :----: | :---: | :---: | :---: | |
|
| 3 | -|:--:|[ACTB](ACTB)|:-:|:-:| |
|
| 4 | -|1|[ARID1A](ARID1A)||[view](images/proteinpaint/ARID1A.svg)|[view](images/proteinpaint/ARID1A_NM_006015.svg)| |
|
| 5 | -|1|[ARID5B](ARID5B)||[view](images/proteinpaint/ARID5B.svg)|[view](images/proteinpaint/ARID5B_NM_032199.svg)| |
|
| 6 | -|1|[B2M](B2M)||[view](images/proteinpaint/B2M.svg)|[view](images/proteinpaint/B2M_NM_004048.svg)| |
|
| 7 | -|1|[BIRC6](BIRC6)||[view](images/proteinpaint/BIRC6.svg)|[view](images/proteinpaint/BIRC6_NM_016252.svg)| |
|
| 8 | -|1-a|[BTG1](BTG1)||[view](images/proteinpaint/BTG1.svg)|[view](images/proteinpaint/BTG1_NM_001731.svg)| |
|
| 9 | -|1|[CARD11](CARD11)||[view](images/proteinpaint/CARD11.svg)|[view](images/proteinpaint/CARD11_NM_032415.svg)| |
|
| 10 | -|1|[CD58](CD58)||[view](images/proteinpaint/CD58.svg)|[view](images/proteinpaint/CD58_NM_001779.svg)| |
|
| 11 | -|1-a|[CD83](CD83)||[view](images/proteinpaint/CD83.svg)|[view](images/proteinpaint/CD83_NM_004233.svg)| |
|
| 12 | -|1|[CDKN2A](CDKN2A)||[view](images/proteinpaint/CDKN2A.svg)|[view](images/proteinpaint/CDKN2A_NM_000077.svg)| |
|
| 13 | -|1|[CHD8](CHD8)||[view](images/proteinpaint/CHD8.svg)|[view](images/proteinpaint/CHD8_NM_001170629.svg)| |
|
| 14 | -|1|[CREBBP](CREBBP)||[view](images/proteinpaint/CREBBP.svg)|[view](images/proteinpaint/CREBBP_NM_004380.svg)| |
|
| 15 | -|1|[CSF2RB](CSF2RB)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CSF2RB.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CSF2RB_protein.html)| |
|
| 16 | -|1|[DDX3X](DDX3X)||[view](images/proteinpaint/DDX3X.svg)|[view](images/proteinpaint/DDX3X_NM_001356.svg)| |
|
| 17 | -|1-a|[DTX1](DTX1)||[view](images/proteinpaint/DTX1.svg)|[view](images/proteinpaint/DTX1_NM_004416.svg)| |
|
| 18 | -|1-a|[DUSP2](DUSP2)||[view](images/proteinpaint/DUSP2.svg)|[view](images/proteinpaint/DUSP2_NM_004418.svg)| |
|
| 19 | -|1-a|[EBF1](EBF1)||[view](images/proteinpaint/EBF1.svg)|[view](images/proteinpaint/EBF1_NM_024007.svg)| |
|
| 20 | -|1|[EP300](EP300)||[view](images/proteinpaint/EP300.svg)|[view](images/proteinpaint/EP300_NM_001429.svg)| |
|
| 21 | -|1-a|[ETS1](ETS1)||[view](images/proteinpaint/ETS1.svg)|[view](images/proteinpaint/ETS1_NM_001143820.svg)| |
|
| 22 | -|1|[EWSR1](EWSR1)||[view](images/proteinpaint/EWSR1.svg)|[view](images/proteinpaint/EWSR1_NM_013986.svg)| |
|
| 23 | -|1|[EZH2](EZH2)||[view](images/proteinpaint/EZH2.svg)|[view](images/proteinpaint/EZH2_NM_001203247.svg)| |
|
| 24 | -|1|[FAS](FAS)||[view](images/proteinpaint/FAS.svg)|[view](images/proteinpaint/FAS_NM_000043.svg)| |
|
| 25 | -|1|[FAT1](FAT1)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/FAT1.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/FAT1_protein.html)| |
|
| 26 | -|1|[FAT4](FAT4)||[view](images/proteinpaint/FAT4.svg)|[view](images/proteinpaint/FAT4_NM_024582.svg)| |
|
| 27 | -|1|[GNA13](GNA13)||[view](images/proteinpaint/GNA13.svg)|[view](images/proteinpaint/GNA13_NM_006572.svg)| |
|
| 28 | -|1|[H1-2](H1-2)(HIST1H1C)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/H1-2.html)|[view](images/proteinpaint/HIST1H1C_NM_005319.svg)| |
|
| 29 | -|1|[H1-3](H1-3)(HIST1H1D)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/H1-3.html)|[view](images/proteinpaint/HIST1H1D_NM_005320.svg)| |
|
| 30 | -|1|[H1-4](H1-4)(HIST1H1E)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/H1-4.html)|[view](images/proteinpaint/HIST1H1E_NM_005321.svg)| |
|
| 31 | -|1|[H1-5](H1-5)(HIST1H1B)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/H1-5.html)|[view](images/proteinpaint/HIST1H1B_NM_005322.svg)| |
|
| 32 | -|1|[HLA-B](HLA-B)||[view](images/proteinpaint/HLA-B.svg)|[view](images/proteinpaint/HLA-B_NM_005514.svg)| |
|
| 33 | -|1-a|[IL4R](IL4R)||[view](images/proteinpaint/IL4R.svg)|[view](images/proteinpaint/IL4R_NM_000418.svg)| |
|
| 34 | -|1-a|[IRF8](IRF8)||[view](images/proteinpaint/IRF8.svg)|[view](images/proteinpaint/IRF8_NM_002163.svg)| |
|
| 35 | -|1-a|[ITPKB](ITPKB)||[view](images/proteinpaint/ITPKB.svg)|[view](images/proteinpaint/ITPKB_NM_002221.svg)| |
|
| 36 | -|1|[JAK1](JAK1)||[view](images/proteinpaint/JAK1.svg)|[view](images/proteinpaint/JAK1_NM_002227.svg)| |
|
| 37 | -|1|[KMT2C](KMT2C)||[view](images/proteinpaint/KMT2C.svg)|[view](images/proteinpaint/KMT2C_NM_170606.svg)| |
|
| 38 | -|1-a|[LTB](LTB)||[view](images/proteinpaint/LTB.svg)|[view](images/proteinpaint/LTB_NM_002341.svg)| |
|
| 39 | -|1-a|[MS4A1](MS4A1)||[view](images/proteinpaint/MS4A1.svg)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/MS4A1_protein.html)| |
|
| 40 | -|1|[NFKBIA](NFKBIA)||[view](images/proteinpaint/NFKBIA.svg)|[view](images/proteinpaint/NFKBIA_NM_020529.svg)| |
|
| 41 | -|1|[NFKBIE](NFKBIE)||[view](images/proteinpaint/NFKBIE.svg)|[view](images/proteinpaint/NFKBIE_NM_004556.svg)| |
|
| 42 | -|1-a|[OSBPL10](OSBPL10)||[view](images/proteinpaint/OSBPL10.svg)|[view](images/proteinpaint/OSBPL10_NM_017784.svg)| |
|
| 43 | -|1|[P2RY8](P2RY8)||[view](images/proteinpaint/P2RY8.svg)|[view](images/proteinpaint/P2RY8_NM_178129.svg)| |
|
| 44 | -|1|[PCLO](PCLO)||[view](images/proteinpaint/PCLO.svg)|[view](images/proteinpaint/PCLO_NM_033026.svg)| |
|
| 45 | -|1|[PHIP](PHIP)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/PHIP.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/PHIP_protein.html)| |
|
| 46 | -|1-a|[PIM1](PIM1)||[view](images/proteinpaint/PIM1.svg)|[view](images/proteinpaint/PIM1_NM_002648.svg)| |
|
| 47 | -|1-a|[PIM2](PIM2)||[view](images/proteinpaint/PIM2.svg)|[view](images/proteinpaint/PIM2_NM_006875.svg)| |
|
| 48 | -|1|[PRKDC](PRKDC)||[view](images/proteinpaint/PRKDC.svg)|[view](images/proteinpaint/PRKDC_NM_006904.svg)| |
|
| 49 | -|1-a|[PTPN1](PTPN1)||[view](images/proteinpaint/PTPN1.svg)|[view](images/proteinpaint/PTPN1_NM_002827.svg)| |
|
| 50 | -|1|[PTPRD](PTPRD)||[view](images/proteinpaint/PTPRD.svg)|[view](images/proteinpaint/PTPRD_NM_002839.svg)| |
|
| 51 | -|1|[RHOA](RHOA)||[view](images/proteinpaint/RHOA.svg)|[view](images/proteinpaint/RHOA_NM_001664.svg)| |
|
| 52 | -|1-a|[S1PR2](S1PR2)||[view](images/proteinpaint/S1PR2.svg)|[view](images/proteinpaint/S1PR2_NM_004230.svg)| |
|
| 53 | -|1-a|[SGK1](SGK1)||[view](images/proteinpaint/SGK1.svg)|[view](images/proteinpaint/SGK1_NM_005627.svg)| |
|
| 54 | -|1|[SIN3A](SIN3A)||[view](images/proteinpaint/SIN3A.svg)|[view](images/proteinpaint/SIN3A_NM_001145358.svg)| |
|
| 55 | -|1|[SMARCA2](SMARCA2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SMARCA2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SMARCA2_protein.html)| |
|
| 56 | -|1|[SMARCA4](SMARCA4)||[view](images/proteinpaint/SMARCA4.svg)|[view](images/proteinpaint/SMARCA4_NM_001128849.svg)| |
|
| 57 | -|1-a|[SOCS1](SOCS1)||[view](images/proteinpaint/SOCS1.svg)|[view](images/proteinpaint/SOCS1_NM_003745.svg)| |
|
| 58 | -|1|[SPEN](SPEN)||[view](images/proteinpaint/SPEN.svg)|[view](images/proteinpaint/SPEN_NM_015001.svg)| |
|
| 59 | -|1|[STAT3](STAT3)||[view](images/proteinpaint/STAT3.svg)|[view](images/proteinpaint/STAT3_NM_139276.svg)| |
|
| 60 | -|1|[STAT6](STAT6)||[view](images/proteinpaint/STAT6.svg)|[view](images/proteinpaint/STAT6_NM_003153.svg)| |
|
| 61 | -|1|[TAP1](TAP1)||[view](images/proteinpaint/TAP1.svg)|[view](images/proteinpaint/TAP1_NM_000593.svg)| |
|
| 62 | -|1|[TBL1XR1](TBL1XR1)||[view](images/proteinpaint/TBL1XR1.svg)|[view](images/proteinpaint/TBL1XR1_NM_024665.svg)| |
|
| 63 | -|1|[TCF3](TCF3)||[view](images/proteinpaint/TCF3.svg)|[view](images/proteinpaint/TCF3_NM_003200.svg)| |
|
| 64 | -|1|[TET3](TET3)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/TET3.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/TET3_protein.html)| |
|
| 65 | -|1-a|[TMSB4X](TMSB4X)||[view](images/proteinpaint/TMSB4X.svg)|[view](images/proteinpaint/TMSB4X_NM_021109.svg)| |
|
| 66 | -|1|[TNFAIP3](TNFAIP3)||[view](images/proteinpaint/TNFAIP3.svg)|[view](images/proteinpaint/TNFAIP3_NM_006290.svg)| |
|
| 67 | -|1|[TNFRSF1B](TNFRSF1B)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/TNFRSF1B.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/TNFRSF1B_protein.html)| |
|
| 68 | -|1|[TP53](TP53)||[view](images/proteinpaint/TP53.svg)|[view](images/proteinpaint/TP53_NM_000546.svg)| |
|
| 69 | -|1|[TRAF3](TRAF3)||[view](images/proteinpaint/TRAF3.svg)|[view](images/proteinpaint/TRAF3_NM_145725.svg)| |
|
| 70 | -|1|[UBE2A](UBE2A)||[view](images/proteinpaint/UBE2A.svg)|[view](images/proteinpaint/UBE2A_NM_003336.svg)| |
|
| 71 | -|1|[UBR5](UBR5)||[view](images/proteinpaint/UBR5.svg)|[view](images/proteinpaint/UBR5_NM_015902.svg)| |
|
| 72 | -|1|[UNC5C](UNC5C)||[view](images/proteinpaint/UNC5C.svg)|[view](images/proteinpaint/UNC5C_NM_003728.svg)| |
|
| 73 | -|1|[VPS13B](VPS13B)||[view](images/proteinpaint/VPS13B.svg)|[view](images/proteinpaint/VPS13B_NM_152564.svg)| |
|
| 74 | -|1-a|[WEE1](WEE1)||[view](images/proteinpaint/WEE1.svg)|[view](images/proteinpaint/WEE1_NM_003390.svg)| |
|
| 75 | -|1|[XPO1](XPO1)||[view](images/proteinpaint/XPO1.svg)|[view](images/proteinpaint/XPO1_NM_003400.svg)| |
|
| 76 | -|1-a|[ZFP36L1](ZFP36L1)||[view](images/proteinpaint/ZFP36L1.svg)|[view](images/proteinpaint/ZFP36L1_NM_004926.svg)| |
tier2_pmbl_hl_gz.md
| ... | ... | @@ -1,35 +0,0 @@ |
| 1 | -| Category | Gene | Details | Mutation frequency | Static view (Gene) | Static view (Protein) | Comment | |
|
| 2 | -| :---: | :----: | :---: | :---: | :---: | |
|
| 3 | -|:--:|[ACTG1](ACTG1)|:-:|:-:| |
|
| 4 | -|2|[ADGRG6](ADGRG6)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/ADGRG6.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/ADGRG6_protein.html)| |
|
| 5 | -|2|[AXDND1](AXDND1)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/AXDND1.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/AXDND1_protein.html)| |
|
| 6 | -|2-a|[BCL7A](BCL7A)||[view](images/proteinpaint/BCL7A.svg)|[view](images/proteinpaint/BCL7A_NM_020993.svg)| |
|
| 7 | -|2|[CCND3](CCND3)||[view](images/proteinpaint/CCND3.svg)|[view](images/proteinpaint/CCND3_NM_001760.svg)| |
|
| 8 | -|2|[CDH5](CDH5)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CDH5.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CDH5_protein.html)| |
|
| 9 | -|2|[CHD2](CHD2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CHD2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CHD2_protein.html)| |
|
| 10 | -|2-a|[CIITA](CIITA)||[view](images/proteinpaint/CIITA.svg)|[view](images/proteinpaint/CIITA_NM_000246.svg)| |
|
| 11 | -|2|[CISH](CISH)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CISH.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/CISH_protein.html)| |
|
| 12 | -|2|[DNAH12](DNAH12)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/DNAH12.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/DNAH12_protein.html)| |
|
| 13 | -|2|[EEF1A1](EEF1A1)||[view](images/proteinpaint/EEF1A1.svg)|[view](images/proteinpaint/EEF1A1_NM_001402.svg)| |
|
| 14 | -|2|[EGR1](EGR1)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/EGR1.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/EGR1_protein.html)| |
|
| 15 | -|2|[HLA-A](HLA-A)||[view](images/proteinpaint/HLA-A.svg)|[view](images/proteinpaint/HLA-A_NM_002116.svg)| |
|
| 16 | -|2|[HLA-C](HLA-C)||[view](images/proteinpaint/HLA-C.svg)|[view](images/proteinpaint/HLA-C_NM_002117.svg)| |
|
| 17 | -|2-a|[IGLL5](IGLL5)||[view](images/proteinpaint/IGLL5.svg)|[view](images/proteinpaint/IGLL5_NM_001178126.svg)| |
|
| 18 | -|2-a|[IRF4](IRF4)||[view](images/proteinpaint/IRF4.svg)|[view](images/proteinpaint/IRF4_NM_002460.svg)| |
|
| 19 | -|2|[IKBKB](IKBKB)||[view](images/proteinpaint/IKBKB.svg)|[view](images/proteinpaint/IKBKB_NM_001556.svg)| |
|
| 20 | -|2|[ITGB2](ITGB2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/ITGB2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/ITGB2_protein.html)| |
|
| 21 | -|2-a|[KLF2](KLF2)||[view](images/proteinpaint/KLF2.svg)|[view](images/proteinpaint/KLF2_NM_016270.svg)| |
|
| 22 | -|2|[KMT2D](KMT2D)||[view](images/proteinpaint/KMT2D.svg)|[view](images/proteinpaint/KMT2D_NM_003482.svg)| |
|
| 23 | -|2|[LIMD2](LIMD2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/LIMD2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/LIMD2_protein.html)| |
|
| 24 | -|2|[MYB](MYB)||[view](images/proteinpaint/MYB.svg)|[view](images/proteinpaint/MYB_NM_001130173.svg)| |
|
| 25 | -|2|[NFKB2](NFKB2)||[view](images/proteinpaint/NFKB2.svg)|[view](images/proteinpaint/NFKB2_NM_001077494.svg)| |
|
| 26 | -|2|[NSD2](NSD2)||[view](images/proteinpaint/NSD2.svg)|[view](images/proteinpaint/NSD2_NM_133330.svg)| |
|
| 27 | -|2|[OR13C2](OR13C2)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/OR13C2.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/OR13C2_protein.html)| |
|
| 28 | -|2|[PCDH7](PCDH7)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/PCDH7.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/PCDH7_protein.html)| |
|
| 29 | -|2|[PCBP1](PCBP1)||[view](images/proteinpaint/PCBP1.svg)|[view](images/proteinpaint/PCBP1_NM_006196.svg)| |
|
| 30 | -|2|[RDH12](RDH12)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/RDH12.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/RDH12_protein.html)| |
|
| 31 | -|2|[RBM38](RBM38)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/RBM38.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/RBM38_protein.html)| |
|
| 32 | -|2|[SCN9A](SCN9A)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SCN9A.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SCN9A_protein.html)| |
|
| 33 | -|2|[SMAD3](SMAD3)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SMAD3.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/SMAD3_protein.html)| |
|
| 34 | -|2|[STRAP](STRAP)||[LOAD](https://morinlab.github.io/LLMPP/GAMBL/STRAP.html)|[LOAD](https://morinlab.github.io/LLMPP/GAMBL/STRAP_protein.html)| |
|
| 35 | -|2|[ZNF217](ZNF217)||[view](images/proteinpaint/ZNF217.svg)|[view](images/proteinpaint/ZNF217_NM_006526.svg)| |